• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高血压的病理生理学:钙拮抗剂对心脏和肾脏的影响

Pathophysiology of hypertension: effects of calcium antagonists on heart and kidney.

作者信息

Frohlich E D

机构信息

Alton Ochsner Medical Foundation, New Orleans, Louisiana 70121.

出版信息

J Cardiovasc Pharmacol. 1989;13 Suppl 1:S11-7.

PMID:2468971
Abstract

Hypertension is a multifactorial disease that is manifested hemodynamically by an increased total peripheral resistance that is more or less uniformly distributed throughout the organ circulations, especially in its target organs, the brain, heart, and kidney. The vasoconstriction involves venules as well as arterioles. The increased afterload that is imposed upon the left ventricle results in the development of concentric hypertrophy. This may be complicated by a preload component early in hypertension or in patients who are volume-dependent (e.g., obesity, blacks). Eventually, if not treated, dysrhythmias, sudden death, or cardiac failure may supervene. The kidney becomes affected by progressive failure in function related to hemodynamic impairment secondary to afferent, as well as efferent, arteriolar constriction, which increases glomerular hydrostatic pressure. If at all possible, antihypertensive therapy should not be associated with intravascular volume expansion or reflex cardiac stimulation. Calcium antagonists reduce arterial pressure through a fall in vascular resistance without expanding volume or inordinately stimulating the heart. Left ventricular afterload is diminished with associated decrease of left ventricular mass. Moreover, renal blood flow increases while filtration fraction and glomerular hydrostatic pressure diminishes. Thus, these agents approach the ideal in reversing the pathophysiological complications of the disease.

摘要

高血压是一种多因素疾病,其血流动力学表现为总外周阻力增加,这种增加或多或少均匀地分布于全身各器官循环,尤其是在其靶器官——脑、心脏和肾脏。血管收缩涉及小静脉以及小动脉。左心室所承受的后负荷增加会导致向心性肥厚。在高血压早期或对于容量依赖性患者(如肥胖者、黑人),这可能会因前负荷因素而变得复杂。最终,如果不进行治疗,可能会出现心律失常、猝死或心力衰竭。肾脏会因入球小动脉和出球小动脉收缩继发的血流动力学损害导致功能逐渐衰竭而受到影响,这会增加肾小球静水压力。只要有可能,抗高血压治疗不应与血管内容量扩张或反射性心脏刺激相关联。钙拮抗剂通过降低血管阻力来降低动脉血压,而不会使血容量增加或过度刺激心脏。左心室后负荷降低,同时左心室质量也会减少。此外,肾血流量增加,而滤过分数和肾小球静水压力降低。因此,这些药物在逆转该疾病的病理生理并发症方面接近理想状态。

相似文献

1
Pathophysiology of hypertension: effects of calcium antagonists on heart and kidney.高血压的病理生理学:钙拮抗剂对心脏和肾脏的影响
J Cardiovasc Pharmacol. 1989;13 Suppl 1:S11-7.
2
Calcium antagonists for initial therapy of hypertension.用于高血压初始治疗的钙拮抗剂。
Heart Lung. 1989 Jul;18(4):370-6.
3
End-organ disease in hypertension: what have we learned?高血压中的终末器官疾病:我们学到了什么?
J Cardiovasc Pharmacol. 1992;20 Suppl 10:S1-6.
4
Reversal of target-organ involvement in systemic hypertension: a pharmacologic experience.系统性高血压靶器官受累的逆转:一项药理学经验。
Am J Cardiol. 1987 Dec 14;60(17):3I-7I. doi: 10.1016/0002-9149(87)90451-6.
5
Renal protection with calcium antagonism in essential hypertension.
Clin Invest Med. 1989 Oct;12(5):300-4.
6
Left ventricular function in hypertension. Relevance to the selection of antihypertensive therapy.高血压患者的左心室功能。与抗高血压治疗选择的相关性。
Am J Hypertens. 1989 Jun;2(6 Pt 2):200S-206S.
7
Renal effects of calcium antagonists with special reference to manidipine hydrochloride.钙拮抗剂对肾脏的影响,特别提及盐酸马尼地平
Blood Press Suppl. 1996;5:10-5.
8
[Are all antihypertensive drugs renoprotective?].[所有抗高血压药物都具有肾脏保护作用吗?]
Herz. 2004 May;29(3):248-54. doi: 10.1007/s00059-003-2508-6.
9
Obesity-associated hypertension: hypothesized link between etiology and selection of therapy.肥胖相关性高血压:病因与治疗选择之间的假定联系
Blood Press Monit. 1999;4 Suppl 1:S23-6.
10
Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.高渗高渗胶体溶液可改善儿童心脏直视手术后的心脏功能。
Pediatrics. 2006 Jul;118(1):e76-84. doi: 10.1542/peds.2005-2795. Epub 2006 Jun 2.